These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31297986)

  • 21. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population.
    Hashimoto A; Chiba N; Tsuno H; Komiya A; Furukawa H; Matsui T; Nishino J; Tohma S
    J Rheumatol; 2015 Apr; 42(4):564-71. PubMed ID: 25593236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of malignancy in Japanese patients with rheumatoid arthritis.
    Yamada T; Nakajima A; Inoue E; Tanaka E; Taniguchi A; Momohara S; Yamanaka H
    Rheumatol Int; 2011 Nov; 31(11):1487-92. PubMed ID: 20473757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
    Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SM; Yamanaka H; Wesby-van Swaay E; Symmons D
    Ann Rheum Dis; 2016 Oct; 75(10):1789-96. PubMed ID: 26621482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohort.
    Slimani S; Lukas C; Combe B; Morel J
    Joint Bone Spine; 2011 Oct; 78(5):484-7. PubMed ID: 21196130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of opportunistic infection in early rheumatoid arthritis.
    Kim H; Cho SK; Lee J; Bae SC; Sung YK
    Int J Rheum Dis; 2019 Jul; 22(7):1239-1246. PubMed ID: 31090187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program.
    Weinblatt ME; Moreland LW; Westhovens R; Cohen RB; Kelly SM; Khan N; Pappu R; Delaet I; Luo A; Gujrathi S; Hochberg MC
    J Rheumatol; 2013 Jun; 40(6):787-97. PubMed ID: 23588946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
    van den Borne BE; Landewé RB; Houkes I; Schild F; van der Heyden PC; Hazes JM; Vandenbroucke JP; Zwinderman AH; Goei The HS; Breedveld FC; Bernelot Moens HJ; Kluin PM; Dijkmans BA
    Arthritis Rheum; 1998 Nov; 41(11):1930-7. PubMed ID: 9811046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.
    Gross RL; Schwartzman-Morris JS; Krathen M; Reed G; Chang H; Saunders KC; Fisher MC; Greenberg JD; Putterman C; Mease PJ; Gottlieb AB; Kremer JM; Broder A
    Arthritis Rheumatol; 2014 Jun; 66(6):1472-81. PubMed ID: 24591475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
    Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
    Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study.
    Staples MP; March L; Hill C; Lassere M; Buchbinder R
    BMC Rheumatol; 2019; 3():1. PubMed ID: 30886989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
    Le Blay P; Mouterde G; Barnetche T; Morel J; Combe B
    Clin Exp Rheumatol; 2012; 30(5):756-64. PubMed ID: 22766000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
    Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
    Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
    Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
    Aaltonen KJ; Joensuu JT; Virkki L; Sokka T; Aronen P; Relas H; Valleala H; Rantalaiho V; Pirilä L; Puolakka K; Uusitalo T; Blom M; Konttinen YT; Nordström D
    J Rheumatol; 2015 Mar; 42(3):372-8. PubMed ID: 25593230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rheumatoid arthritis and malignancy].
    Kameda T; Dobashi H
    Nihon Rinsho; 2016 Jun; 74(6):1017-21. PubMed ID: 27311195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
    England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cancer among rheumatoid arthritis patients in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2009 Aug; 20(6):1001-10. PubMed ID: 19184473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.
    Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.
    Dreyer L; Cordtz RL; Hansen IMJ; Kristensen LE; Hetland ML; Mellemkjaer L
    Ann Rheum Dis; 2018 Apr; 77(4):510-514. PubMed ID: 29217620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.
    Harigai M; Tanaka E; Inoue E; Sakai R; Sugitani N; Toyoizumi S; Sugiyama N; Yamanaka H
    Rheumatol Ther; 2024 Oct; 11(5):1181-1195. PubMed ID: 39017907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.